TY - JOUR
T1 - Diagnostic accuracy of saliva-based testing as a Vibrio cholerae surveillance tool among naturally infected patients
AU - Chisenga, Caroline C.
AU - Phiri, Bernard
AU - Ng’ombe, Harriet
AU - Muchimba, Mutinta
AU - Liswaniso, Fraser
AU - Bernshtein, Biana
AU - Cunningham, Adam F.
AU - Sack, David
AU - Bosomprah, Samuel
N1 - Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved.
PY - 2025/1/1
Y1 - 2025/1/1
N2 - Saliva, as a diagnostic medium, offers a promising alternative to blood by virtue of its non-invasive collection, which enhances patient compliance, especially in paediatric and geriatric populations. In this study, we assessed the utility of saliva as a non-invasive medium for measuring Vibrio cholerae-specific serum antibodies in naturally infected individuals. We tested paired serum and saliva samples obtained from a total of 63 patients with cholera enrolled in a cohort study. Vibriocidal antibodies assay (IgM/IgG) as markers for accurate determination was used to determine cholera-specific antibody levels. Using receiver operating characteristics (ROC) curve, we found that the best cut-off that maximizes (sensitivity + specificity) is 10 titres. At this saliva titre, the sensitivity is 76.9% (95%CI: 60.9%, 87.7%) and specificity is 80.0% (95%CI: 56.6%, 92.5%). Using Spearman’s correlation coefficient, we also found evidence of a positive correlation between V. cholerae saliva and serum antibodies (rho = 0.66, P < 0.001). In conclusion, saliva-based diagnostic cholera tests have high diagnostic accuracy and would be advantageous, cheaper, and quicker for early diagnosis of severe cholera outcomes.
AB - Saliva, as a diagnostic medium, offers a promising alternative to blood by virtue of its non-invasive collection, which enhances patient compliance, especially in paediatric and geriatric populations. In this study, we assessed the utility of saliva as a non-invasive medium for measuring Vibrio cholerae-specific serum antibodies in naturally infected individuals. We tested paired serum and saliva samples obtained from a total of 63 patients with cholera enrolled in a cohort study. Vibriocidal antibodies assay (IgM/IgG) as markers for accurate determination was used to determine cholera-specific antibody levels. Using receiver operating characteristics (ROC) curve, we found that the best cut-off that maximizes (sensitivity + specificity) is 10 titres. At this saliva titre, the sensitivity is 76.9% (95%CI: 60.9%, 87.7%) and specificity is 80.0% (95%CI: 56.6%, 92.5%). Using Spearman’s correlation coefficient, we also found evidence of a positive correlation between V. cholerae saliva and serum antibodies (rho = 0.66, P < 0.001). In conclusion, saliva-based diagnostic cholera tests have high diagnostic accuracy and would be advantageous, cheaper, and quicker for early diagnosis of severe cholera outcomes.
KW - cholera
KW - natural infection
KW - saliva
KW - vibriocidal antibodies
UR - http://www.scopus.com/inward/record.url?scp=85216680575&partnerID=8YFLogxK
U2 - 10.1093/cei/uxae092
DO - 10.1093/cei/uxae092
M3 - Article
C2 - 39432681
AN - SCOPUS:85216680575
SN - 0009-9104
VL - 219
JO - Clinical and Experimental Immunology
JF - Clinical and Experimental Immunology
IS - 1
M1 - uxae092
ER -